Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-06-05
1998-01-13
MacMillan, Keith
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514540, 514541, 514676, A61K 3712, A61K 3744, A61K 3318
Patent
active
057080305
ABSTRACT:
The present invention relates to the use in the treatment of cognitive disorders associated with the aging processes of the brain and perinatal brain disorders of compounds which act as inhibitors of the enzyme kynurenine aminotransferase (KAT).
REFERENCES:
Japanese Patent Application No. J8 2018-458 of Tanable SeiyakuKK (Abstract) Apr. 16, 1982.
Chemical Abstracts, vol. 93, 1980, 239866u.
J. Med. Chem., 1994, 37, 334-36.
Society for Neuroscience, vol. 19, 1993, Abstract 554.7.
Society for Neuroscience, vol. 18, 1992, Abstract 482.12.
Adv. in Enzym. 1979, 49, 1-40.
Chemical Abstracts, vol. 79, 1973, 28836g.
Chemical Abstracts AN 1992; 564604, Gramsberger et al, 1992.
Bianchetti Alberto
Della Torre Arturo
Schwarcz Robert
Speciale Carmela
Varasi Mario
MacMillan Keith
Pharmacia & Upjohn S.p.A.
University of Maryland
LandOfFree
Substituted kynurenines and process for their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted kynurenines and process for their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted kynurenines and process for their preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326774